Immunosuppression [[electronic resource] ] : new research / / Charles B. Taylor, editor

• Record Nr.: UNINA9910823408303321
• Pubbl/distr/stampa: New York, : Nova Science Pub. Inc., 2009
• ISBN: 1-60876-707-8
• Edizione: [1st ed.]
• Descrizione fisica: 1 online resource (320 p.)
• Altri autori (Persone): TaylorCharles B
• Disciplina: 615.37
• Soggetti: Immunosuppression; Immunosuppressive agents
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Note generali: Description based upon print version of record.
• Nota di bibliografia: Includes bibliographical references and index.
• Nota di contenuto: ""Immunosuppression: New Research""; ""Contents""; ""Preface""; ""Is There a Future for Costimulation Blockade as a Regulatory T-cell Inducing Therapy?""; ""Abstract""; ""Introduction""; ""Costimulation Blockade""; ""Regulatory T-Cells""; ""Conclusion""; ""References""; ""Strategies for T Cell Depletion to Prevent Graft versus Host Disease""; ""Abstract""; ""Introduction""; ""Pharmacological Intervention""; ""T Cell Depletion - An Effective Non-PharmacologicImmunosuppression""; ""Pre â€?Clinical Models and Early Clinical Studies""; ""Strategies of T Cell Depletion""; ""Merits and Problems with TCD""""Haploidentical Transplantation""; ""Strategies to Improve Outcome of Patients with TCell Depletion""; ""Conclusions""; ""References""; ""Leucocyte Intracellular Cytokines in Lung Transplant Patients- A More Physiological Indicator of Immunosuppression than Plasma Drug Levels""; ""Abstract""; ""Introduction""; ""Acute and Chronic Transplant Rejection""; ""Immunosuppression""; ""Conclusion""; ""References""; ""Indications and Management of m-TOR Inhibitors after Liver Transplantation""; ""Abstract""; ""Introduction""; ""Objectives""; ""Material and Methods""; ""Results""""Discussion""; ""References""; ""Evolution of Immunosuppression in Liver Transplantation""; ""Abstract""; ""Abbreviations""; ""Introduction""; ""Evolution of Immunosuppression""; ""Recent Advances in ImmunosuppressionFollowing Liver Transplantation""; ""Conclusion""; ""References""; ""The Role of ; Pharmacogenomics in Tailoring Immunosuppressive Therapy for Liver Transplant Recipients""; ""Abstract""; ""Introduction""; ""Current Immunosuppressive Drugs""; ""Pharmacogenomics and Drug Metabolism""; ""Genetic Polymorphism and Immunosuppressive Drugs""; ""Limitations of Clinical application of Pharmacogenomics""""Conclusion""; ""References""; ""Immunosuppression Caused by Photochemo- and Photodynamic Therapy: Focus on Photosensitizer Photoproducts""; ""Abstract""; ""Introduction""; ""Suppression of Delayed Type Hypersensitivity (DTH) Reaction by Products of Photosensitizer Photooxidation""; ""Suppression of Contact Hypersensitivity (CHS) by PUVA-Treatment and by Photosensitizer Photoproducts""; ""POP Therapy Is a New Patient-Friendly Photochemotherapy That Requires No UV-A Irradiation of Skin or Blood""; ""Conclusion""; ""References""; ""Sunlight Induced Immunosuppression: A Role for Inflammatory Mediators in the Induction of Suppressor Cells""""Abstract""; ""Introduction""; ""Immunosuppression Only Requires Exposure toLow Doses of UV Radiation""; ""Sunlight Is Immunosuppressive""; ""UV-Induced Regulatory Cells""; ""Factors Involved in the Activationof UV-Regulatory Cells""; ""Dendritic Cells as Mediators of Regulatory T Cell Activation""; ""Mast Cells and the Activation of RegulatoryPopulations in Secondary Lymphoid Tissues""; ""Regulatory B Cells as Facilitatorsof UV-Immunosuppression""; ""Conclusion""; ""References""; ""Immunosuppressive Therapy in Adult to Adult Living-Related Liver Transplantation""